Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 4861-4868, September 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manchester, D. K.
Right arrow Articles by Okey, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manchester, D. K.
Right arrow Articles by Okey, A. B.

Ah Receptor in Human Placenta: Stabilization by Molybdate and Characterization of Binding of 2,3,7,8-Tetrachlorodibenzo-p-dioxin, 3-Methylcholanthrene, and Benzo(a)pyrene1

David K. Manchester, Stephen K. Gordon2, Cheryl L. Golas, Eve A. Roberts and Allan B. Okey3

Departments of Pediatrics and Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262 [D. K. M., S. K. G.] and Division of Clinical Pharmacology, Department of Pediatrics, Research Institute, The Hospital for Sick Children and Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada M5G 1X8 [C. L. G., E. A. R., A. B. O.]

Aryl hydrocarbon hydroxylase (AHH, cytochrome P1-450) is highly inducible in several human cells and tissues exposed to specific halogenated and nonhalogenated aromatic chemicals of the "3-methylcholan-threne-type." In laboratory animals AHH induction is known to be regulated by binding of inducers to the Ah receptor, a soluble intracellular protein. However, the induction mechanism in the human species is incompletely understood largely because the Ah receptor, which seems to be essential to the induction process, has not previously been detectable in certain human cells and tissues (including placenta) that are highly responsive to AHH induction. We found that human placenta contains high concentrations of Ah receptor (comparable to the receptor concentrations in rat and mouse liver) but that special modifications were necessary in the assay techniques in order to detect and accurately quantitate receptor binding. Receptor was detected at concentrations {approx}100 fmol/mg cytosol protein using [3H]2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) as the radioligand. This high concentration of specific binding sites was present only if the placental tissue was initially homogenized in a buffer containing sodium molybdate (10 or 20 mM). Without molybdate in the homogenizing buffer, specific [3H]TCDD binding was only about 35 fmol/mg. Specific Ah receptor binding also was detectable with [3H]-3-methylcholanthrene and, to a lesser extent, with [3H]-benzo(a)pyrene. The receptor sedimented near 9S on sucrose gradients whether molybdate was present or not. About 80% of specific binding was lost if excessive charcoal was used to adsorb "nonspecifically bound" ligand from cytosol prior to gradient analyses. The apparent affinity with which [3H]TCDD bound to Ah receptor in human placental cytosol was relatively low (apparent Kd {approx} 5 to 8 nM) when compared with the affinity of [3H]TCDD binding in rat or mouse hepatic cytosols (Kd {approx} 1 to 3 nM). These data suggest that while molybdate has very little effect on the quantity or molecular size of the rodent Ah receptor assay, it is very important in stabilizing the human Ah receptor. Our experiments demonstrate that human placenta contains a high concentration of Ah receptor and suggest that AHH induction in placenta is mediated through a receptor mechanism analogous to that previously established in tissues and cells from laboratory animals.

1 Supported by a Grant from the National Cancer Institute of Canada to A.B.O.

2 Supported by NIH Short-term Training Grant TSAM07496.

3 To whom requests for reprints should be addressed, at the Division of Clinical Pharmacology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8.

Received 2/13/87. Revised 5/28/87. Accepted 6/24/87.




This article has been cited by other articles:


Home page
Toxicol SciHome page
A. B. Okey
An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI
Toxicol. Sci., July 1, 2007; 98(1): 5 - 38.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
K. Augustowska, Z. Magnowska, M. Kapiszewska, and E. L. Gregoraszczuk
Is the natural PCDD/PCDF mixture toxic for human placental JEG-3 cell line? The action of the toxicants on hormonal profile, CYP1A1 activity, DNA damage and cell apoptosis
Human and Experimental Toxicology, May 1, 2007; 26(5): 407 - 417.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. I. Karchner, D. G. Franks, S. W. Kennedy, and M. E. Hahn
The molecular basis for differential dioxin sensitivity in birds: Role of the aryl hydrocarbon receptor
PNAS, April 18, 2006; 103(16): 6252 - 6257.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Pollenz and E. J. Dougherty
Redefining the Role of the Endogenous XAP2 and C-terminal hsp70-interacting Protein on the Endogenous Ah Receptors Expressed in Mouse and Rat Cell Lines
J. Biol. Chem., September 30, 2005; 280(39): 33346 - 33356.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Tang, J. H. Lin, and A. Y. H. Lu
METABOLISM-BASED DRUG-DRUG INTERACTIONS: WHAT DETERMINES INDIVIDUAL VARIABILITY IN CYTOCHROME P450 INDUCTION?
Drug Metab. Dispos., May 1, 2005; 33(5): 603 - 613.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Ramadoss and G. H. Perdew
Use of 2-Azido-3-[125I]iodo-7,8-dibromodibenzo-p-dioxin as a Probe to Determine the Relative Ligand Affinity of Human versus Mouse Aryl Hydrocarbon Receptor in Cultured Cells
Mol. Pharmacol., July 1, 2004; 66(1): 129 - 136.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. A. Jensen and M. E. Hahn
cDNA Cloning and Characterization of a High Affinity Aryl Hydrocarbon Receptor in a Cetacean, the Beluga, Delphinapterus leucas
Toxicol. Sci., November 1, 2001; 64(1): 41 - 56.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. E. Heid, R. S. Pollenz, and H. I. Swanson
Role of Heat Shock Protein 90 Dissociation in Mediating Agonist-Induced Activation of the Aryl Hydrocarbon Receptor
Mol. Pharmacol., January 1, 2000; 57(1): 82 - 92.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
R. Pohjanvirta, J. M. Y. Wong, W. Li, P. A. Harper, J. Tuomisto, and A. B. Okey
Point Mutation in Intron Sequence Causes Altered Carboxyl-Terminal Structure in the Aryl Hydrocarbon Receptor of the Most 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Resistant Rat Strain
Mol. Pharmacol., July 1, 1998; 54(1): 86 - 93.
[Abstract] [Full Text]


Home page
ScienceHome page
E. Hoffman, H Reyes, F. Chu, F Sander, L. Conley, B. Brooks, and O Hankinson
Cloning of a factor required for activity of the Ah (dioxin) receptor
Science, May 17, 1991; 252(5008): 954 - 958.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.